EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Switching Off Vascular MAPK Signaling: A Novel Strategy to Prevent Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage

Lars Edvinsson, Diana N Krause

Translational Stroke Research · 2025-06 · 16 (3) · 952-961

DOI: 10.1007/s12975-024-01234-z ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Translational Stroke Research, online erschienen am 09.02.2024. Verfasst von Lars Edvinsson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Experimental Vascular Research, Department of Clinical Sciences, Lund University, Sölvegatan 19, 22100, Lund, Sweden. lars.edvinsson@med.…. Hauptthemen laut MEDLINE: Subarachnoid Hemorrhage, Brain Ischemia, MAP Kinase Signaling System. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Heart and Lung Foundation, Svenska Forskningsrådet Formas, The Lundbeck Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients who initially survive the rupture and repair of a brain aneurysm often take a devastating turn for the worse some days later and die or suffer permanent neurologic deficits. This catastrophic sequela is attributed to a delayed phase of global cerebral ischemia (DCI) following aneurysmal subarachnoid hemorrhage (aSAH), but we lack effective treatment. Here we present our view, based on 20 years of research, that the initial drop in blood flow at the time of rupture triggers genomic responses throughout the brain vasculature that manifest days later as increased vasoconstriction and decreased cerebral blood flow. We propose a novel treatment strategy to prevent DCI by early inhibition of the vascular mitogen-activated protein kinase (MAPK) pathway that triggers expression of vasoconstrictor and inflammatory mediators. We summarize evidence from experimental SAH models showing early treatment with MAPK inhibitors “switches off” these detrimental responses, maintains flow, and improves neurological outcome. This promising therapy is currently being evaluated in clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Subarachnoid HemorrhageBrain IschemiaMAP Kinase Signaling SystemHumansAnimalsCerebrovascular Circulation

Stichwörter der Autor:innen

Cerebral vasculatureDelayed cerebral ischemiaMAPK kinase inhibitorSubarachnoid hemorrhageVasoconstriction

Autor:innen und Institutionen

  • Division of Experimental Vascular Research, Department of Clinical Sciences, Lund University, Sölvegatan 19, 22100, Lund, Sweden. lars.edvinsson@med.lu.se.
  • Department of Experimental Research, Glostrup Research Institute, CopenhagenUniversity, Copenhagen, Denmark. lars.edvinsson@med.lu.se.
  • Division of Experimental Vascular Research, Department of Clinical Sciences, Lund University, Sölvegatan 19, 22100, Lund, Sweden.
  • Department of Pharmaceutical Sciences, SchoolofPharmacy&PharmaceuticalSciences, University of California at Irvine, Irvine, CA, USA.

Förderung

  • Swedish Heart and Lung Foundation
  • Svenska Forskningsrådet Formas
  • The Lundbeck Foundation
  • Lund University

Zitieren

APA

Edvinsson, L., & Krause, D. N. (2025). Switching Off Vascular MAPK Signaling: A Novel Strategy to Prevent Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage. Translational Stroke Research, 16(3), 952-961. https://doi.org/10.1007/s12975-024-01234-z

Vancouver

Edvinsson L, Krause DN. Switching Off Vascular MAPK Signaling: A Novel Strategy to Prevent Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage. Translational Stroke Research. 2025;16(3):952-961. doi:10.1007/s12975-024-01234-z

BibTeX
@article{Edvinsson2025,
  author = {Edvinsson, Lars and Krause, Diana N},
  title = {Switching Off Vascular MAPK Signaling: A Novel Strategy to Prevent Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage},
  journal = {Translational Stroke Research},
  year = {2025},
  volume = {16},
  number = {3},
  pages = {952--961},
  doi = {10.1007/s12975-024-01234-z}
}
Kostenlos starten →